COYA Coya: מכפיל EV/EBITDA

The EV/EBITDA price chart for Coya Therapeutics, Inc. (COYA) is currently at 0.00. The absence of commercial products is offset by strategic partnerships while T-cell therapies remain under development. In the future, proprietary technologies are expected to ensure stable revenue driven by high demand. Meanwhile, Coya Therapeutics, Inc. (COYA) is minimizing costs by outsourcing production and testing to third-party contractors.

The EV/EBITDA multiple compares the total enterprise value, including debt, to operating profit before taxes and amortization, allowing for an assessment of the asset's real value regardless of the financing structure. By analyzing the EV/EBITDA metric of Coya Therapeutics, Inc. (COYA) across a financial timeline, an investor determines the efficiency of the capital expenditures required by Coya Therapeutics, Inc. (COYA) to maintain complex biomaterial logistics while developing treatments for neurodegeneration.